The way medicines are developed and made is changing. While drug discovery has become faster, smarter and increasingly data-driven, pharmaceutical manufacturing still faces challenges in flexibility, scalability and efficiency. Bridging this gap between scientific discovery and industrial application is at the heart of CMAC’s mission.

CMAC collaborates with N4 Pharma on a new technical evaluation project, marking a milestone in CMAC’s mission to support industry in accelerating the development of transformative medicines.

New CMAC research reveals that tablet strength loss at high production speeds is due to increased lubricant distribution from faster feedframe paddle rotation, not compression speed. Using Huxley Bertram’s HB50 simulator, the team isolated variables and replicated industrial conditions.

The CMAC Data Lab is entering a transformative era in drug development and manufacturing. As part of CMAC’s commitment to innovation and research excellence, we’ve integrated cutting-edge Knowledge Graph software from Plvs Ultra into our research facility.

Lonza has joined CMAC as a Translation to Industry Collaborator to enhance its service offering for specialty and enhanced drug product and particle technologies

CMAC has appointed John Mack as a new member of its Industry Board. Representing CMAC’s Tier 2 membership, John’s role will enhance the Tier 2 community's connection to CMAC’s activities, ensuring the centre stays at the forefront of manufacturing advancements and continues to meet the evolving needs of its members.

At DM2, we recognize the vital role of public trust in the integration of digital technologies in medicine manufacturing. Through our outreach efforts we engaged a local community, gathering insights and addressing concerns about AI and robotics in healthcare. By fostering open dialogue, we aim to shift perceptions, paving the way for a brighter future in medicine.

Global CDMO Ajinomoto Bio-Pharma Services has become the first organisation to position itself as a Translation to Industry Collaborator within CMAC, a world-leading centre for medicines manufacturing at the University of Strathclyde.

CMAC launches campaign encouraging postdoctoral researchers from around the globe, to apply for a prestigious Marie Skłodowska-Curie Actions (MSCA) Postdoctoral Fellowship.

The EPSRC MediForge Hub will transform the development and manufacturing of medicines by pioneering an Industry 5.0 manufacturing system for sustainable, resilient, and human-centric medicine production.

In a significant stride towards advancing nanoparticle drug delivery manufacturing technology, leon-nanodrugs GmbH (LEON), has proudly announced a pioneering technical evaluation by CMAC, University of Strathclyde.

This ground-breaking CDT is set to revolutionise the pharmaceutical and technology sectors by addressing critical skills needs within the industry.

The University of Strathclyde’s Continuous Manufacturing and Advanced Crystallisation (CMAC) are delighted to announce a new £11 million award from UK Research Partnership Investment Fund (UKRPIF) to deliver the CMAC Data Lab: A Digital Medicine Manufacturing Research Accelerator. 

In continuation of our monthly “Meet our Team” post, we are celebrating CMAC’s Operational Coordinator and PA To the Directors, Morell Kerr.

In our first Meet our Team post, we are celebrating CMAC's PhD student Peter Hou, who began working with CMAC in 2019.